ISSCR Consortium: Stem Cell-Based Models in Drug Discovery
This webinar covers the ISSCR Consortium's mission to establish validation frameworks, benchmarking standards, and best practices for NAMs. Learn how stem cell models, organoids, and MPS are shaping safer, more predictive drug discovery and supporting global regulatory shifts with 3Rs compliance, FDA, and EMA guidelines.
Publish Date:
June 15, 2026
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to şŁ˝ÇĆĆ˝â°ć Technologies Canada Inc. and its subsidiaries and affiliates (“şŁ˝ÇĆĆ˝â°ć”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
This site is protected by reCAPTCHA and the Ěý˛ą˛Ô»ĺĚýĚý˛ą±č±č±ô˛â.
This site is protected by reCAPTCHA and the Ěý˛ą˛Ô»ĺĚýĚý˛ą±č±č±ô˛â.
Related Multimedia
-
Using Stem Cell-Based Models in Drug Discovery
Publish Date: August 19, 2024 -
NAMs in Regulatory Toxicology: Challenges & Considerations
Publish Date: June 15, 2026 -
Drug Discovery with In Vitro NAMs: Expert Roundtable
Publish Date: June 15, 2026
Explore Our Products
-
STEMdiff™ Hepatic Organoid Media
Serum-free cell culture media for the growth and differentiation of hepatic organoids from hPSC-derived hepatocyte-like cells -
IntestiCult™ Plus Organoid Growth Medium
Serum- and conditioned medium-free intestinal organoid cell culture medium for expansion and differentiation of human intestinal organoids -
Serum- and BPE-free culture medium for the expansion of human large airway, small airway, and nasal epithelial cells
